LTR Pharma LimitedASX: LTP

Clinical and Commercial Update - Investor Webinar

· Issued by LTR Pharma Limited via ASX

Filed with ASX ·

1800 519 711 | ltrpharma.com | [email protected] LTR Pharma Limited (ABN 64 644 924 569 / ACN 644 924 569) Clinical and Commercial Update: Investor Webinar 2 October 2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to invite its shareholders and other...

View Attachment

6ix hasn’t read this filing yet.

LTR Pharma Limited on 6ix

Story so far

Earlier from LTR Pharma

Later from LTR Pharma

All LTR Pharma news releases